Compare Becton Dickinson and Co (BDX) vs Cardinal Health Inc (CAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Cardinal Health Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while Cardinal Health Inc trades at $240.52 (market cap $55.88B). The key difference: Becton Dickinson and Co and Cardinal Health Inc are close in size by market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | CAH | |
|---|---|---|
Market Cap | $49.41B | $55.88B |
Sector | Health | Health |
52-Week High | $185.39 | $240.26 |
52-Week Low | $138.62 | $146.04 |
Enterprise Value | $65.51B | $59.91B |
Dividend Yield | 2.32% | 0.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →
